Sex Disparities in Hypoxic Sympatholysis and Impact of Obesity

July 24, 2026 updated by: Jacqueline K Limberg, PhD, University of Missouri-Columbia
Patients with sleep apnea are at increased risk of developing cardiovascular disease - with women at potentially greater risk than men. Contributing mechanisms are not well understood, but may be related to how women respond to low oxygen and, given over 70% of patients with sleep apnea are obese, the impact of obesity. This project seeks to increase our understanding of mechanisms that may contribute to sex differences in the cardiovascular response to low oxygen with the hope that this knowledge will improve the efficacy of current therapies and support the discovery of novel therapeutics.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

73

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Missouri
      • Columbia, Missouri, United States, 65211
        • University of Missouri-Columbia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 18-45 years of age (premenopausal)
  • Healthy weight (BMI ≥18 and ≤25 kg/m2)
  • Obese (BMI ≥30 kg/m2)

Exclusion Criteria:

  • Pregnancy, breastfeeding, oral hormonal contraceptive use
  • Diagnosed sleep apnea or Oxygen desaturation index >10 events/hr
  • Current smoking/Nicotine use
  • Increased risk of bleeding, pro-coagulant disorders, clotting disorders, anticoagulation therapy
  • Nerve/neurologic disease
  • Cardiovascular, hepatic, renal, respiratory disease
  • Blood pressure ≥140/90 mmHg
  • Diabetes, Polycystic ovarian syndrome
  • Communication barriers
  • Prescription medications, Sensitivity to lidocaine

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Hypoxia Exposure
Participants will undergo room air (normoxic) and low oxygen (hypoxic) conditions.
Participants will complete the cold pressor test during the final 2 min of normoxia and hypoxia.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in forearm vascular conductance with cold pressor test
Time Frame: Continuous measurement of vascular conductance during cold pressor test (final 2 min of normoxia and hypoxia).
Vascular conductance is an index of vascular tone and is measured using a technique called venous occlusion plethysmography.
Continuous measurement of vascular conductance during cold pressor test (final 2 min of normoxia and hypoxia).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 9, 2020

Primary Completion (Actual)

July 2, 2026

Study Completion (Actual)

July 2, 2026

Study Registration Dates

First Submitted

June 8, 2020

First Submitted That Met QC Criteria

June 15, 2020

First Posted (Actual)

June 18, 2020

Study Record Updates

Last Update Posted (Actual)

July 28, 2026

Last Update Submitted That Met QC Criteria

July 24, 2026

Last Verified

July 1, 2026

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe